pharmaceutical investing Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent
pharmaceutical investing VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101
pharmaceutical investing Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
